Bayer Faces Setbacks as €7.25 Billion Roundup Settlement Raises Questions

 

Bayer's shares tumbled by 9.2% following the announcement of a $7.25 billion settlement for cancer lawsuits linked to its Roundup weedkiller. Investors are questioning the settlement's decisiveness as uncertainties remain regarding the required court approvals and potential Supreme Court rulings on the case's merits.

https://www.devdiscourse.com/article/science-environment/3809263-bayer-faces-setbacks-as-725-billion-roundup-settlement-raises-questions